SCL Global Policy Initiative

SCL Global Policy InitiativeSCL Global Policy InitiativeSCL Global Policy InitiativeSCL Global Policy Initiative
  • Home
  • About Us
  • Contact Us
  • Statements & Releases
  • Board of Advisors

SCL Global Policy Initiative

SCL Global Policy InitiativeSCL Global Policy InitiativeSCL Global Policy Initiative
  • Home
  • About Us
  • Contact Us
  • Statements & Releases
  • Board of Advisors

Statement by SCLC President and CEO Dr. Charles Steele, Jr.

  

Atlanta, GA- SCLC President and CEO Dr. Charles Steele, Jr. “Memphis Police Killing Shows how deeply embedded racism is in the police culture!”

Download PDF

Article Published in SCLC magazine

Download PDF

SLC-GPI Blog posts and news

SLC-GPI releases health equity white paper

The COVID-19 pandemic and social unrest surrounding racial disparities and systemic racism have put renewed emphasis on closing health and wealth gaps.


Prescription drug pricing, always a hot topic in the battle for equity, has been at the forefront of 

this conversation. The disproportionate impact of COVID-19 intensified the scrutiny on access to medicines, co-morbidity, and other issues surrounding health equity.


While many of the issues surrounding prescription drug pricing have focused singularly on the manufacturers, this paper seeks to examine the current state of play in the prescription drug supply chain and marketplace.


In this paper, the authors reviewed the role of the 340B program, Pharmacy Benefit Managers (PBMs), Copay Accumulators, and the phenomenon of pharmacy deserts in the utilization of prescription drugs, their costs, and impact on racial health disparities.

Download PDF

SLC-GPI statement on HR 3

Download PDF

article highlighting recent SCLC protest

Download PDF

Statement on Ugandan elections

Download PDF

PDF Viewer

Download PDF

Copyright © 2023 SCL Global Policy Initiative - All Rights Reserved.

Powered by GoDaddy